biomed 101
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2000 (NCT00004890)
Timeline
2000s
- Jan 1, 2000
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Leukotriene B4 receptorINHIBITOR
Leukotriene B4 receptor inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- biomed 101
- biomed 101
- biomed 101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00004890 | Phase 1 | Dec 1, 2000 | Impact Biomedicines, National Cancer Institute (NCI), University of California, Los Angeles |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Impact Biomedicines | For profit | 1 | 1 | 1 | 2000 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2000 |
| University of California, Los Angeles | Academic/Hospital | 1 | 0 | 1 | 2000 |
3 organizations
Page 1 / 1